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Bisphenol A (BPA), a ubiquitous environmental
contaminant, has been shown to cause developmental
toxicity and carcinogenic effects. BPA may have physiological
activity through estrogen receptor (ER) -α and -β, which
are expressed in the central nervous system. We previously
found that exposure of BPA to immature mice resulted in
behavioral alternation, suggesting that overexposure of
BPA could be neurotoxic. In this study, we further
investigated the molecular neurotoxic mechanisms of BPA.
BPA increased vulnerability (decrease of cell viability and
differentiation, and increase of apoptotic cell death) of
undifferentiated PC12 cells and cortical neuronal cells
isolated from gestation 18 day rat embryos in a
concentration-dependent manner (more than 50 µM). The
ER antagonists, ICI 182,780, and tamoxifen, did not block
these effects. The cell vulnerability against BPA was not
significantly different in the PC12 cells overexpressing
ER-α and ER-β compared with PC12 cells expressing
vector alone. In addition, there was no difference observed
between BPA and 17-β estradiol, a well-known agonist of
ER receptor in the induction of neurotoxic responses.
Further study of the mechanism showed that BPA
significantly activated extracellular signal-regulated kinase
(ERK) but inhibited anti-apoptotic nuclear factor kappa
B (NF-κB) activation. In addition, ERK-specific inhibitor,
PD 98,059, reversed BPA-induced cell death and restored
NF-κB activity. This study demonstrated that exposure to
BPA can cause neuronal cell death which may eventually
be related with behavioral alternation in vivo. However,
this neurotoxic effect may not be directly mediated
through an ER receptor, as an ERK/NF-κB pathway may
be more closely involved in BPA-induced neuronal toxicity.
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Introduction
Environmental estrogen-like chemicals have been
increasingly recognized as potentially hazardous factors for
human health. Some examples of this diverse group of
compounds include industrial chemicals (e.g., bisphenol A,
alkyl phenols, phthalates, polychlorinated biphenyls) and
pesticides (e.g., DDT, methoxychlor, dieldrin, toxaphene,
endosulfan). These estrogen-like chemicals are becoming
ubiquitous in the environment, and humans are being
exposed to these chemicals through the food chain [11].
Bisphenol A (BPA), an environmental estrogen, has been
used as a compound in food and drink cans [5], as well as
being a component of plastic in dental fillings. BPA has
been reported to have not only estrogenic activity in the E-
screen test and luciferase activity assay [31], but it also has
several other biological toxicities.
Eye, nose, throat, and skin irritation and a number of cases
of skin sensitization and photosensitization have been
reported in man in relation to BPA toxicity. BPA also
possessed immunotoxicity and reduced the non-specific
host defense system [39]. In addition, recent reports
demonstrated that maternal exposure to BPA affected
reproductive function [41]. BPA administration during the
entire period of pregnancy in rats was reported to produce
pregnancy failure, pre- and post-implantation loss, fetal
developmental delay, and severe maternal toxicity [18].
BPA decreased the frequency of blastocyst development  in
vitro [40]. However, little is known regarding the effects of
BPA on the neurons, even though BPA causes embryo and
developmental toxicity [18,40]. We previously found that
exposure of immature mice (3-week-old) to BPA for 3
weeks resulted in neurobehavioral alteration [36].
The toxic effects of BPA have been proposed to be
mediated through binding to estrogen receptor (ER)-α or -β
[42]. For example, BPA reduced hepatic metallothionein
synthesis and increased damage to the liver after Cd
injection, and these effects occurred via an ER-mediated
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mechanism [38]. BPA-induced increases in uterine wet
weight and in luminal epithelial height in the ovariectomized
B6C3F1 mouse are mediated by ERs [30]. The ligand
binding domains of ER-α and ER-β are very similar in their
tertiary architecture, and many compounds bind ER-α and
ER-β with similar affinities [20] or with similar potencies in
activation of estrogen responsive element-mediated receptor
gene expression [3]. However, there is a difference in the
distributions of ER-α and ER-β [19]. The uterus, breast,
pituitary, bone, and cardiovascular tissue are known to be
ER-α target organs [8], whereas the ventral prostate, ovarian
granulosa cells [26], and gonadotropin-releasing hormone-
containing neurons in the brain [12], sympathetic ganglia
[44], and immune system [37] are targets of ER-β. In
addition, differential biological responses have been
reported to have estrogenic compound-induced toxic effects
depending on whether those chemical agents act through
ER-α or ER-β [23]. However, the neurotoxic mechanism of
BPA, and the relevance of its neurotoxicity to ER have not
yet been studied.
Activation of the mitogen activation protein (MAP)
kinase family is known to be related to cellular toxic events
and numerous physiological processes such as neuronal cell
death and differentiation [32]. Transcription factor, nuclear
factor kappa B (NF-κB), is linked to neurite formation, as
well as survival and death of neuronal cells [9]. Extracellular
signal-regulated kinase (ERK) has an important temporal
regulator in the form of NF-κB activation and NF-κB-
dependent gene expression [16]. NF-κB also down regulates
c-Jun N-terminal kinase (JNK) activation, which promotes
cell death [34]. These signals have been implicated in the
neurotoxic mechanisms of estrogenic environmental
neurotoxic materials, unless they do not act through ER. Our
previous study demonstrated that interference of differentiation
of neuronal cells may be a critical factor in neuronal cell
survival, and differential activation of the MAP kinase
family and transcription factors are involved in survival
processes [17], ochratoxin-induced neurotoxicity [27], TNF-
α-induced cortical neuronal cell death [39], and Zn-induced
interference of PC12 cell differentiation [35]. Therefore, in
the present study, we investigated whether BPA causes
PC12 cells and neuronal cell death in a dose-dependent
manner, and further investigated whether the neurotoxic




ICI 182,780 (Tocris, USA), Tamoxifen, PD 98,059, SB
203,580, SP 600,125, BPA, and 17-β estradiol (Sigma-
Aldrich, USA) were dissolved in dimethyl sulfoxide (DMSO;
Sigma-Aldrich, USA). These chemicals were dissolved with
complete medium to the desired concentrations immediately
prior to use. PD 98,059, SB 203,580, SP 600,125, Tamoxifen,
and ICI 182,780 pre-treatments were performed 30 min
before the addition of BPA. The final concentration of
DMSO was less than 0.2%.
Cell culture
PC12 cells that have differentiation capacity were maintained
on tissue culture plastic in Dulbecco’s modified Eagle’s
medium (DMEM) and Ham’s F-12 nutrient (Invitrogen, USA)
supplemented with 10% heat-inactivated horse serum, 5%
fetal bovine serum, 100 µg/ml penicillin, and 100 µg/ml
streptomycin at 37
oC in a 5% CO2 atmosphere. PC12 cells
overexpressing ER as well as a control and PC12 cells
expressing vector alone were routinely maintained in the
above conditions to compare their viabilities. To induce
differentiation of PC12 cells, nerve growth factor (NGF) (50
ng/ml) was added in DMEM supplied with only 1% heat-
inactivated horse serum as described elsewhere [16]. Neuronal
cells were prepared from E18 rat cortex (Sprague-Dawley
rat brains) trypsinized (trypsin/EDTA) for 15 min at 37
oC
and dissociated using a fire-polished Pasteur pipette. The
resulting cell suspension was added to poly-L-lysine-coated
dishes containing in neurobasal media supplemented with B
27 serum (Invitrogen, USA). The dishes were incubated at
37
oC in 5% CO2 for the designated amounts of time.
Transfection of PC12 cells
Human ER-β cDNA was produced from human testis
mRNA (BD Bioscience Clontech, USA) by PCR amplification,
and it was then ligated into the PGEM-T easy vector to yield
a hERβ cDNA fragment (1,672 bp) containing Not I and
Spe I restriction sites. Neuron specific enolase (NSE)-hER β
cDNA (6,264 bp) was obtained by ligation of the above-
mentioned hERβ cDNA with NSE promoter that was
cloned in PCMVβ with Not I and Spe I digestion. Human
ERα cDNA (pCMV5-hERα) or NSE-hERβ cDNA was
transiently transfected into PC12 cells. PC12 cells were
seeded onto 96-well tissue culture plates and grown in
normal growth medium. The cells were incubated until they
reached approximately 50-60% confluence. We prepared
solution A (200 ng ER-α or β plasmid in 100 µl serum-free
DMEM) and solution B (5 µl Lipofectamine Plus reagents
(Life Technology, USA) in 95 µl serum-free DMEM per
well). We combined the two solutions, which were mixed
and incubated at room temperature for 20 min, and then
overlaid the diluted complex solution onto the cells washed
once with serum-free DMEM. The medium was exchanged
with normal growth medium at 4 h after transfection. The
transiently ER-α and -β transfected cells were referred to as
PC12/ER-α and PC12/ER-β cells, respectively. The cells
stimulated in the transient transfection conditions with only
vector were named PC12/neo cells.Estrogen receptor independent neurotoxic mechanism of bisphenol A, an environmental estrogen 29
WST-1 assay
After deleting the medium and then adding 90 µl PBS, 10
µl of WST-1 reagent (Roche, Germany) was added to each
well (96-well plates). The cells were then incubated with the
WST-1 reagent for 3 h in 5% CO2 at 37
oC. Following
incubation, the absorbance at 450 nm was determined using
a microplate reader (Megellan Software; Tecan, Austria).
Cell viability was expressed as the percentage of absorbance
obtained in the treated wells relative to that in the untreated
control wells.
DAPI staining
Cells were cultured on 8-chamber slides. After treatment
with compound for 24 h, the cells were washed with PBS
and fixed with 4% paraformaldehyde at room temperature
for 30 min. After fixation, dishes were washed with PBS
and incubated at room temperature with 1 drop of 4,6-
diamidino-2-phenylindole (DAPI) solution (Vector, USA)
for 30 min in the dark. After DAPI staining, apoptotic cells
were determined according to the morphological changes
through fluorescence microscope (Leica Microsystems AG,
Germany).
Western blotting
Cells were homogenized with lysis buffer: 50 mM Tris,
pH 8.0, 150 mM NaCl, 0.02% sodium azide, 0.2% SDS,
1 mM phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin,
1% igepal CA 630 (Sigma-Aldrich, USA), 10 mM NaF, 0.5
mM EDTA, 0.1 mM EGTA, and 0.5% sodium deoxycholate,
and were then centrifuged. Equal amounts of proteins were
separated on a SDS/12% polyacrylamide gel and then
transferred to a nitrocellulose membrane. Blots were
blocked for 2 h with 5% (w/v) nonfat dried milk in Tris-
buffered saline (10 mM Tris, pH 8.0, and 150 mM NaCl)
solution containing 0.05% Tween-20. The membrane was
then incubated for 3 h with specific primary antibodies,
followed by incubation for 1 h with secondary antibodies.
Rabbit polyclonal antibodies against ERK, p38, JNK, and
mouse monoclonal antibodies against phosphorylated forms
of MAP kinase (1 : 500) (Santa Cruz Biotechnology, USA)
were used. Immunoreactive proteins were detected with the
enhanced chemiluminescence Western blotting detection
system. The relative density of the protein bands was evaluated.
Nuclear extract and gel mobility shift assay
The gel mobility shift assay was performed using a slight
modification of a method described previously [17]. In brief,
the cultured cells were washed three times with ice-cold
phosphate-buffered saline, pH 7.6, and pelleted. The pellets
were resuspended in 400 µl of nonradioactive buffer
containing 10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl,
0.5 mM dithiothreitol, and 0.2 mM phenylmetylsulfonyl
fluoride, and were then centrifuged to remove everything
except the nuclei. The pellets were resuspended in a second
buffer containing 20 mM HEPES, 20% glycerol, 420 mM
NaCl, 0.2 mM EDTA, 1.5 mM MgCl2, 0.5 mM dithiothreitol,
and 0.2 mM phenylmethylsulfonyl fluoride. After centrifugation,
the supernatant contained the nuclear protein. The protein
level was determined by a microplate modification of the
Bradford method [4]. Then, 10 µg of nuclear protein was
incubated in a total volume of 10 µl of binding buffer
(10 mM Tris, pH 7.5, 1 mM MgCl2, 0.5 mM EDTA, 50 mM
NaCl, 0.5 mM dithiothreitol, 0.05 µg/µl poly(dl-dC) ·
poly(dl-dC), 4% glycerol) at 4
oC for 15 min, followed by
another 20 min incubation with 100 µCi of γ-
32P ATP-labeled
oligonucleotide containing NF-κB binding sites. The DNA
protein binding complex was run a 6% nondenatured
polyacrylamide gel at 150 V for 2 h. Gels were dried and
autographed using Kodak MR film at −80
oC overnight. The
relative density of the DNA binding bands was evaluated.
Statistics
The data were expressed as mean ± SE. In cases of
significant variation, the individual values were compared
by t-test in all experiments.
Results
BPA inhibits neural extension and induces neuronal
cell death
In this study, we examined the cytotoxic effects of BPA
assessed by the WST-1 method. PC12 cells were cultured
for 12, 24, 48, and 72 h in the condition of non-treated
medium or with several doses of BPA-treated medium. The
viability of cortical neuronal cells was determined after 72 h
treatments with several concentrations of BPA. As seen in
Fig. 1A and 2A, concentrations below 50 µM slightly
increased cell viability, but at concentrations higher than 100
µM, BPA reduced the viability significantly in both types of
cells. Untreated PC12 cells as well as cortical neurons
contained round nuclei with homogeneous chromatin,
whereas cells exposed to more than 100 µM BPA for 24 h
showed a reduction in nuclear size and chromatin condensation,
as well as nuclear fragmentation, all of which are typical
features of apoptosis (Fig. 1B & 2B). These findings suggest
that BPA can induce cell death through apoptosis.
Considerable extension of neurites was observed in PC12
cells and cortical neurons after treatment with NGF (50 ng/
ml) for 5 days (Fig. 1C & 2C). BPA at low concentrations
(0-10 µM in PC12 and cortical neuronal cells) could
increase neurite extension, but high concentrations (more
than about 50 µM) reduced neurite extension.
Effects of estrogen inhibitors against BPA-induced cell
death
To investigate whether damage to cells induced by BPA
was mediated by ER, cells were pretreated with ER
antagonists (tamoxifen, ICI 182,780) 30 min prior to30 Yoot Mo Lee et al.
treatment with BPA, and we examined PC12 and cortical
neuronal cell survival using the WST-1 assay or neurite
extension. ER antagonists did not abolish BPA-induced
toxicity in PC12 cells, as well as cortical neuronal cells (Fig.
3A & 4A). In addition, ER antagonists also did not have
significant effects on BPA-induced neurite shrinkage of the
2 types of cells (Fig. 3B & 4B). These findings seem to
reflect that ER may not be related with neuronal cell damage
induced by BPA.
Cell vulnerability against BPA in PC12 cells overexpressing
ER or expressing vector alone
To further confirm the involvement of ER-α or ER-β in
BPA-induced neuronal cell damage, we compared the
viability of PC12 using PC12 cells expressing vector alone
(PC12/neo cells) and PC12 cells transfected with ER-α or
ER-β cDNA after culturing with several concentrations of
BPA. The toxic responses among the cells did not differ
(Fig. 5B) even though PC12 cells expressing ER-α and ER-
β showed 3- to 4-fold increases in ER expression (Fig. 5A).
No difference between BPA and 17-β estradiol in the
induction of neurotoxic responses
We also compared the susceptibility of PC12 and cortical
neuronal cells against BPA or 17-β estradiol using the WST-
1 assay. The cell viability was determined after 72 h incubation
with these chemicals. The 17-β estradiol-induced viability
was similar to that induced by BPA in both cell types (Fig.
5C). This result may indicate that BPA-induced cell damages
are exerted at lower levels through the classical ER-
mediated intracellular receptor signal transduction system,
and suggests the possibility that one or more additional
Fig. 1. Effect of BPA on PC12 cell viability. (A) Cell viability of PC12 cells after 12, 24, 48, and 72 h treatments with/without severa l
concentrations of BPA. Living cells were represented as a percentage of the total population of living and dead cells. (B)
Photomicrographs of DAPI-stained PC12 cells treated for 24 h with several concentrations of BPA. Cells were stained with DAPI to
visualize nuclear morphology. The percentage of apoptosis which presents a reduction in nuclear size, chromatin condensation, a nd
nuclear fragmentation from two experiments was entered into a graph. (C) Photomicrographs of PC12 cells treated with the indica ted
materials for 5 days, respectively. PC12 cells were cultivated for 1 day in the condition of non-treated DMEM supplemented wit h
Ham’s F12 nutrient, 1% horse serum, 50 ng/ml NGF, 100 units/ml penicillin, and 100  µg/ml streptomycin, and were then cultured with/
without several concentrations of BPA added to the medium. Control (Con), those cultured with/without BPA and NGF. *Significan t
difference from control (p <0 . 0 5 ) .Estrogen receptor independent neurotoxic mechanism of bisphenol A, an environmental estrogen 31
signal-mediated mechanisms are more significant in BPA-
induced neurotoxicity.
Activation of MAP kinase signals in BPA-induced
neurotoxicity
MAP kinase activation was determined by examining
the induction of p38, JNK, and ERK, as well as their
phosphorylation (p-p38, p-JNK, and p-ERK). After 2 h
exposure to BPA, protein was extracted from PC12 cells and
cortical neuronal cells, and was then subjected to Western
analysis using each antibody that recognizes the MAP kinase
family (p38, JNK, and ERK) and their phosphorylations.
BPA increased the expression of p38, JNK, ERK and their
phosphorylations, but only activation of ERK was clearly
increased in a dose-dependent manner (Fig. 6). To study
protective effects of MAP kinase inhibitions on BPA toxicities,
we examined the cytotoxic effects of BPA with or without
the MAP kinase inhibitors (PD 98,059, SB 203,580, and SP
600,125) assessed by the WST-1 method. Among them,
only PD 98,059 (an ERK inhibitor) reversed BPA-induced
toxicity of PC12 cells and neuronal cells. The other MAP
kinase inhibitors did not reverse against BPA toxicities.
However, it seems that the proper dose of PD 98,059 needed
to protect BPA-induced neuronal damage varied. That is to
say, 20 µM PD 98,059 showed the highest protective effect
on PC12 cells, but a much higher dose (50-100 µM) of PD
98,059 was required to protect against BPA-induced cortical
neuronal cell death (Fig. 7).
BPA-induced neurotoxic effect is related with a decrease
of NF-κB activity
We also examined the activation of transcription factor
NF-κB since it is known to act as a cell survival factor. The
highest activations of NF-κB were seen in BPA (10 µM)-
Fig. 2. Effect of BPA on cortical neuronal cell viability. (A) Cell viability of neuronal cells after 72 h treatments with/without vari ous
concentrations of BPA. Living cells were represented as a percentage of the total population of living and dead cells. (B)
Photomicrographs of DAPI-stained neuronal cells treated for 24 h with various concentrations of BPA. Cells were stained with DAP I to
visualize nuclear morphology. The percentage of apoptosis which presents a reduction in nuclear size, chromatin condensation, a nd
nuclear fragmentation from two experiments was entered into a graph. (C) Photomicrographs of neuronal cells treated with BPA fo r 5
days, respectively. Neuronal cells were cultivated for 1 day in the condition of non-treated neurobasal medium supplemented wit h B 27
serum, and then cultured with/without several concentrations of BPA added to the medium. Control (Con), those cultured with/wit hout
BPA. *Significant difference from control (p <0 . 0 5 ) .32 Yoot Mo Lee et al.
Fig. 3. BPA-induced PC12 cell death was not mainly mediated by estrogen receptor. PC12 cells were treated with ER antagonist 30 mi n
prior to treatment with BPA. (A) Viability of PC12 cell cultures was determined after treatment with compounds for 3 days. (B)
Photomicrographs of PC12 cells cultured with BPA with/without ER antagonists added to DMEM supplemented with Ham’s F12
nutrient, 5% fetal bovine serum, 10% horse serum, 50 ng/ml NGF, 100 units/ml penicillin, and 100  µg/ml streptomycin for 5 days.
*Significant difference from control (p <0 . 0 5 ) .
Fig. 4. BPA-induced neuronal cell death was not mainly mediated by estrogen receptor. Neurocortical (neuronal) cells were treated wit h
ER antagonist 30 min prior to treatment with BPA. (A) Viability of neuronal cell cultures was determined after treatment wit h
compounds for 3 days. (B) Photomicrographs of neuronal cell cultures cultured with BPA with/without ER antagonists added to
neurobasal media supplemented with B 27 serum for 5 days. *Significant difference from control ( p <0 . 0 5 ) .Estrogen receptor independent neurotoxic mechanism of bisphenol A, an environmental estrogen 33
treated cells for 90 min. To determine the effects of BPA for
NF-κB activations, PC12 and cortical neuron cells were
treated with 0, 10, 50, 100, and 200 µM BPA for 90 min.
The highest activations of NF-κB were seen in PC12 and
cortical neuron cells treated with 10 µM BPA (Fig. 8A & B),
which corresponded to the promoting effect of BPA on cell
survival. However, decreases of NF-κB occurred in toxic
concentrations of BPA (50-200 µM) as compared with
Fig. 5. BPA toxicity in PC12, PC12/neo, PC12/ER-α, or β cells. (A) Expression of ERs in established PC12 cells expressing ER- α and
β. (B) Comparison of four cell types according to a viability assay performed 72 h after BPA treatments. The four cell types were
cultured with/without several concentrations of BPA. (C) Comparison between BPA and 17- β estradiol on cell viability according to
concentration using the WST-1 method. Viability was assayed in PC12 cells and neuronal cells treated with different concentrati ons of
BPA and 17-β estradiol for 72 h. *Significant difference from control ( p <0 . 0 5 ) .
Fig. 6. Effect of BPA concentrations for activations of the MAP kinase family. Cells were treated with BPA, and after 2 h exposure to
BPA, activation of MAP kinase family was determined by Western blotting. Similar patterns of expression were found from three
individual experiments.34 Yoot Mo Lee et al.
10 µM BPA-induced NF-κB activity. Next, we tested the
effects of tamoxifen, ICI 182,780, and PD 98,059 for BPA-
dependent NF-κB inactivation. PC12 and neuronal cells
were pretreated with ER antagonists for 30 min and then
stimulated with BPA for 90 min. As shown in Fig. 8C and
D, a decrease of NF-κB activation induced by a toxic dose
of BPA (100 µM) obviously was not reversed by ER
antagonists in PC12 and neuronal cells. To further study the
relevance of the ERK pathway in BPA-induced inactivation
of NF-κB to cause a neurotoxic response, both cells were
pretreated with ERK inhibitor PD 98,059 at 30 min prior to
treatment with BPA, and NF-κB activity was then
determined after 90 min of treatment with BPA. As
expectated and in accordance with cell viability, PD 98,059
reversed BPA (100 µM)-induced NF-κB inactivation in
both types of cell (Fig. 8E & F).
Discussion
The present study showed that BPA reduced cell survival
of PC12 and cortical neuronal cells dose-dependent manner,
and this reduction was not reversed by ER antagonists.
However, the susceptibility of ER-overexpressing PC12
cells was similar to that of PC12 cells overexpressing vector
alone. Consistent with the dose-dependent increase of
susceptibility, our experiments showed that BPA increased
activation of ERK. However, the NF-κB activation level
was reduced. Moreover, ERK inhibited the reversal of BPA-
induced neuronal cell death and NF-κB. These results show
that BPA causes neurotoxic events, and also indicated that
activation of the ERK pathway accompanied with decreases
of NF-κB rather than the ER pathway seems to be related to
BPA-induced neurotoxicity.
The dose causing neuronal cell death in this study (more
than 50 µM) is comparable to the dose inducing cell death in
rat Sertoli cells [14]. However, a low dose of BPA (less than
50 µM) may aid in the neurite extension of cells, which
resulted in increased cell viability. It was reported that low
concentrations of BPA exert neuroprotective effects against
glutamate and amyloid beta toxicities [12]. The low dose-
induced cell protective effect was partially prevented in the
presence of ER antagonists (data not shown), which suggests
that the protective effect may be mediated by ER. However,
the neurotoxic response induced by a high dose was not
mediated by ER. Therefore, these data suggest that BPA has
a dose-differential effect on cell survival, and a concentration
of about 50 µM may be a cut-off dose to cause either
protective or toxic effects on neuronal cells. Although it has
been reported that BPA toxicity may be mediated by ER in
other cells [43], it may not have had much influence in
neuronal cell death. This notion was supported by the
present data showing that ER antagonists did not significantly
affect BPA-induced neurotoxicities. In addition, the toxic
effect of 17-β estradiol was similar to that of BPA in PC12
cells and neuronal cells, although it was reported that the
estrogenic activity of BPA is one-third to one-quarter that of
estradiol [2]. Moreover, there were no significant differences
in the susceptibility to BPA between the PC12 cells
overexpressed with ER-α or ER-β cDNA (ER-α or β/PC12)
and vector alone transfected in PC12 cells. In connection
with our findings, it was reported that BPA induced marked
malformations and specific apoptosis of central nervous
system cells during early development of X. laevis embryos,
and that these BPA effects appeared to be due to non-
estrogenic activities on developmental processes [28]. Neuronal
apoptosis resulting from high doses of the isoflavone
genistein, known to be an estrogenic compound, also is not
blocked by an ER antagonist, ICI 182,780. In their study,
increased intracellular calcium and p42/44 MAP kinase
were suggested as ER-independent toxic mechanisms [23].
It was also noteworthy that estrogenic response Sertoli cells
incubated with nonestrogenic compounds such as 2',3',4',5'-
tetrachloro-4-biphenylol and 3,3',4,4'-tetrachlorobiphenyl
(estrogenic contaminants), but not with 10
−7 M 17-β estradiol,
showed morphological changes [33]. Moreover, a recent
study showed that BPA strongly bound to ER-related receptor
Fig. 7. Protective effects of ERK inhibitor on BPA toxicity. PC12
and neuronal cells were pretreated with MAP kinase inhibitors
(PD 98,059, SB 203,580, and SP 600,125) followed by BPA (300
µM) treatment. After 72 h of exposure, we examined PC12 and
neuronal cell survival using the WST-1 assay. Living cells were
represented as a percentage of the total population of living an d
dead cells. *Significant difference from control ( p <0 . 0 5 ) .
#Significant difference from only BPA-treated group ( p <0 . 0 5 ) .Estrogen receptor independent neurotoxic mechanism of bisphenol A, an environmental estrogen 35
compared to ER-α and ER-β, which may interrupt direct
binding of BPA to ER-α and ER-β [42]. Taken together,
these results clearly demonstrated that BPA causes
neurotoxicities, but BPA-induced neurotoxic effects may not
be directly mediated by ER.
Activation of members of the MAP kinase family has
been known to mediate death of several cell types, including
neuronal cells [32]. Our previous data have also shown that
the MAP kinase family is activated depending on the cell
type and nature of stimuli in the neuronal cell survival
[17,27]. Therefore, we investigated the alteration of MAP
kinase signals to determine whether these signals may be
related with BPA-induced neurotoxic effects. BPA activated
all three types in the MAP kinase family, but only activation
of ERK was clearly dose-dependent. Moreover, in the
presence of ERK inhibitor, a BPA-induced neurotoxic effect
was prevented, but that of other inhibitors was not, which
suggested that ERK pathway activation could be involved in
the neurotoxic effect of BPA. Activation of the ERK
pathway as a neurotoxic mechanism has been reported on
extensively. Stimulations of intracellular calcium signaling
and CREB phosphorylation in mid-brain neuron death
during development are associated with neurotrophin
signaling by activation of MAP kinase [21]. ERK is also
activated in neuronal cell death by reactive oxygen species
(ROS), and its inhibition rescues cells from ROS-induced
death [35]. MPTP, a neurotoxin used widely in Parkinson’s
disease experimental paradigms, induces activation of ERK,
while its inhibition rescues the affected cells [10]. ERK
inhibition also reduces toxicity following cerebral ischemia
[1]. The elements leading to ERK activation include
intracellular signal molecules such as thromboxane A 2,
intracellular calcium, angiotensin II, insulin, and ROS
[24,35]. BPA-induced ERK activation may be affected by
these elements in various ways. Among them, alteration of
intracellular calcium concentration could be a significant
contributor to the activation of ERK, thereby inhibiting cell
survival. In fact, we previously found that BPA significantly
lowered intracellular calcium concentrations of PC12 cells
and cortical neuron cells in a dose-dependent manner [22].
In connection with the direct calcium lowering effect of
BPA, estradiol inhibited ATP-induced intracellular calcium
concentration in dorsal root ganglia neurons, which may
modulate nociceptive signaling in the peripheral nervous
system [6]. It was also reported that angiotensin-induced
Ras/ERK activation is dominantly regulated by G q-coupled
Ca
2+/calmodulin signaling in cardiac fibroblast cell death
[25]. Therefore, it seems that the activation of ERK by
depletion of intracellular calcium may be linked to the
neurotoxicity of BPA.
Fig. 8. Effect of BPA, ER antagonists, and ERK inhibitor on NF- κB activation. PC12 cells (A) and cortical neuronal cells (B) were
treated with 0, 10, 50, 100, and 200 µM (BPA) for 90 min with/without pretreatment of different doses of ER antagonists (tamoxife n
and ICI 182,780) (C & D) or ERK inhibitor (E & F) 30 min prior to treatment with BPA. Nuclear extracts were prepared and assaye d for
NF-κB by EMSA from two individual experiments performed in duplicate.36 Yoot Mo Lee et al.
In addition, our results demonstrated that a low
concentration of BPA resulted in the development of a
significant increase of the transcription factor, NF-κB,
which is thought to protect cell survival. However, higher
doses of BPA decreased NF-κB activity. Some evidence has
accumulated to indicate that the activation of NF-κB might
rescue cells from oxidative stress-induced neuronal cell
death, suggesting that NF-κB activation may be an
important signal to prevent cellular degeneration [29]. Based
on our experiments, the transcription factors stimulated by
BPA (low dose) may lead to support weak neurite outgrowths
and maintainance of survival or proliferation, but high doses
of BPA resulted in decreasing the effect of NF-κB, which
may not be able to protect cells against BPA-induced cell
death. However, the BPA-induced decrease of NF-κB
activation was not reversed by ER antagonists, which again
suggests that the ER pathway is not involved in BPA-
induced neurotoxicity or NF-κB inactivation. In contrast,
ERK inhibitor reversed a BPA-induced down-regulation of
NF-κB and neuronal cell death, suggesting the involvement
of the ERK pathway in the BPA-induced neurotoxic effects.
These data suggests that down-activation of NF-κB may be
another significant contributing factor in the BPA-induced
neurotoxic mechanism.
In conclusion, BPA has a dose-dependent effect on
neuronal toxicity, but the toxic effect may not be mediated
by ER. The excess ERK stimulation accompanied by NF-
κB inactivation is linked to BPA-induced neurotoxicity. It
was reported that the normal serum BPA concentration in
women is approximately 1-2 ng/ml (about 5-10 nM), and
the amniotic fluid concentration of BPA is an approximately
8.5 ± 0.2 ng/ml (about 40 nM) [15]. Therefore, the
concentration of BPA used in the present study was much
higher (about 100-2,000 higher level) than the normal
environmental exposure level. However, it is thought that
the concentration of BPA in the blood could reach in the
micro-molar range in the case of high-dose oral
supplementation or intravenous therapy. In addition, BPA
may increase physiological effects in combination with
natural hormones. Thus, even though it does not waken the
public interest at present, the potential for neurotoxicity of
BPA needs to be considered in future studies.
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